Pharmacological relationship between nicotinic and opioid systems in analgesia and corticosterone elevation

Life Sciences

Volumn 89, Issue 25-26, 2011, Pages 956-961

  Yamamoto, Akihiro ^a   Kiguchi, Norikazu ^a   Kobayashi, Yuka ^a   Maeda, Takehiko ^b   Ueno, Keiko ^a   Yamamoto, Chizuko ^a   Kishioka, Shiroh ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Antinociception; Morphine; Nicotinic acetylcholine receptor; 4 2; 7

Indexed keywords

CORTICOSTERONE; DIHYDRO BETA ERYTHROIDINE; MECAMYLAMINE; METHYLLYCACONITINE; MORPHINE; NALOXONE; NICOTINE; NICOTINIC RECEPTOR; OPIATE RECEPTOR; NARCOTIC ANALGESIC AGENT; NICOTINIC AGENT;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CORTICOSTERONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MALE; MOUSE; NONHUMAN; ANIMAL; BLOOD; DISEASE MODEL; DRUG ADMINISTRATION; FLUOROMETRY; HYPOPHYSIS ADRENAL SYSTEM; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PAIN; SIGNAL TRANSDUCTION; SUBCUTANEOUS DRUG ADMINISTRATION;

MUS;

ANALGESICS, OPIOID; ANIMALS; CORTICOSTERONE; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; FLUOROMETRY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MICE, INBRED ICR; MORPHINE; NICOTINE; NICOTINIC AGONISTS; PAIN; PITUITARY-ADRENAL SYSTEM; RECEPTOR CROSS-TALK;

EID: 84855744762     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.10.004     Document Type: Article

References (48)

1. Abdin MJ, Morioka N, Morita K, Kitayama T, Kitayama S, Nakashima T, et al. Analgesic action of nicotine on tibial nerve transection (TNT)-induced mechanical allodynia through enhancement of the glycinergic inhibitory system in spinal cord. Life Sci 2006;80(1):9-16.
2. Armario A. Activation of the hypothalamic-pituitary-adrenal axis by addictive drugs: different pathways, common outcome. Trends Pharmacol Sci 2010;31(7):318-25.
3. Berrendero F, Kieffer BL, Maldonado R. Attenuation of nicotine-induced antinocicep-tion, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 2002;22(24):10935-40.
4. Berrendero F, Mendizabal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, et al. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J Neurosci 2005;25 (5):1103-12.
5. Buckingham JC. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology 1982;35(2):111-6.
6. Buckingham JC, Cooper TA. Differences in hypothalamo-pituitary- adrenocortical activity in the rat after acute and prolonged treatment with morphine. Neuroendocri-nology 1984;38(5):411-7.
7. Caggiula AR, Epstein LH, Antelman SM, Saylor SS, Perkins KA, Knopf S, et al. Conditioned tolerance to the anorectic and corticosterone-elevating effects of nicotine. Pharmacol Biochem Behav 1991;40(1):53-9.
8. Clarke PB, Reuben M. Release of [3H]-noradrenaline from rat hippocampal synapto-somes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 1996;117(4):595-606.
9. Damaj MI, Fei-Yin M, Dukat M, Glassco W, Glennon RA, Martin BR. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. J Pharmacol Exp Ther 1998;284(3):1058-65.
10. Damaj MI, Meyer EM, Martin BR. The antinociceptive effects of alpha7 nicotinic agonists in an acute pain model. Neuropharmacology 2000;39(13):2785-91.
11. Decker MW, Meyer MD, Sullivan JP. The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control. Expert Opin Investig Drugs 2001;10(10): 1819-30.
12. Dhatt RK, Gudehithlu KP, Wemlinger TA, Tejwani GA, Neff NH, Hadjiconstantinou M. Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine. J Neurochem 1995;64(4):1878-83.
13. Galeote L, Kieffer BL, Maldonado R, Berrendero F. Mu-opioid receptors are involved in the tolerance to nicotine antinociception. J Neurochem 2006;97(2):416-23.
14. Galeote L, Maldonado R, Berrendero F. Involvement of kappa/dynorphin system in the development of tolerance to nicotine-induced antinociception. J Neurochem 2008;105(4):1358-68.
15. Gotti C, Zoli M, Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006;27(9):482-91.
16. Houdi AA, Dasgupta R, Kindy MS. Effect of nicotine use and withdrawal on brain pre-proenkephalin A mRNA. Brain Res 1998;799(2):257-63.
17. Ignar DM, Kuhn CM. Effects of specific mu and kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J Pharmacol Exp Ther 1990;255(3):1287-95.
18. Kiguchi N, Maeda T, Tsuruga M, Yamamoto A, Yamamoto C, Ozaki M, et al. Involvement of spinal Met-enkephalin in nicotine-induced antinociception in mice. Brain Res 2008;1189:70-7.
19. Krueger RJ, Lin CM, Fung YK. Effect of chronic administration of nicotine or cocaine on steroidogenesis in rat adrenocortical cells. J Pharm Pharmacol 1991;43(3):200-3.
20. Maeda T, Hamabe W, Gao Y, Fukazawa Y, Kumamoto K, Ozaki M, et al. Morphine has an antinociceptive effect through activation of the okadaic-acid-sensitive Ser/Thr protein phosphatases PP 2 A and PP5 estimated by tail-pinch test in mice. Brain Res 2005;1056(2):191-9.
21. Marubio LM, del Mar Arroyo-Jimenez M, Cordero-Erausquin M, Lena C, Le Novere N, de Kerchove d'Exaerde A, et al. Reduced antinociception in mice lacking neuronal nic-otinic receptor subunits. Nature 1999;398(6730):805-10.
22. Mathieu-Kia AM, Besson MJ. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat. Brain Res Mol Brain Res 1998;54(1):141-51.
23. Matsumoto M, Xie W, Inoue M, Ueda H. Evidence for the tonic inhibition of spinal pain by nicotinic cholinergic transmission through primary afferents. Mol Pain 2007;3: 41.
24. Matta SG, Beyer HS, McAllen KM, Sharp BM. Nicotine elevates rat plasma ACTH by a central mechanism. J Pharmacol Exp Ther 1987;243(1):217-26.
25. Matta SG, McAllen KM, Sharp BM. Role of the fourth cerebroventricle in mediating rat plasma ACTH responses to intravenous nicotine. J Pharmacol Exp Ther 1990;252 (2):623-30.
26. Mayer DJ, Mao J, Holt J, Price DD. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci U S A 1999;96(14):7731-6.
27. Mellon RD, Bayer BM. The effects of morphine, nicotine and epibatidine on lymphocyte activity and hypothalamic-pituitary-adrenal axis responses. J Pharmacol Exp Ther 1999;288(2):635-42.
28. Nadeau G, Sobolewski G. Tolerance to drugs, especially to morphine. Nature 1960;186: 169-70.
29. Pfeiffer A, Herz A. Endocrine actions of opioids. Horm Metab Res 1984;16(8):386-97.
30. Quick MW, Lester RA. Desensitization of neuronal nicotinic receptors. J Neurobiol 2002;53(4):457-78.
31. Rashid MH, Ueda H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 2002;953(1-2):53-62.
32. Rashid MH, Furue H, Yoshimura M, Ueda H. Tonic inhibitory role of alpha4beta2 subtype of nicotinic acetylcholine receptors on nociceptive transmission in the spinal cord in mice. Pain 2006;125(1-2):125-35.
33. Robinson SE, Vann RE, Britton AF, O'Connell MM, James JR, Rosecrans JA. Cellular nico-tinic receptor desensitization correlates with nicotine-induced acute behavioral tolerance in rats. Psychopharmacology (Berl) 2007;192(1):71-8.
34. Tripathi HL, Martin BR, Aceto MD. Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. J Pharmacol Exp Ther 1982;221(1):91-6.
35. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991;251(4989):85-7.
36. Valentine JD, Matta SG, Sharp BM. Nicotine-induced cFos expression in the hypotha-lamic paraventricular nucleus is dependent on brainstem effects: correlations with cFos in catecholaminergic and noncatecholaminergic neurons in the nucleus tractus solitarius. Endocrinology 1996;137(2):622-30.
37. Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J, et al. Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989;284(2):314-35.
38. Wang XQ, Imaki T, Shibasaki T, Yamauchi N, Demura H. Intracerebroventricular administration of beta-endorphin increases the expression of c-fos and of corticotropin-releasing factor messenger ribonucleic acid in the paraventricular nucleus of the rat. Brain Res 1996;707(2):189-95.
39. Wang Y, Su DM, Wang RH, Liu Y, Wang H. Antinociceptive effects of choline against acute and inflammatory pain. Neuroscience 2005;132(1):49-56.
40. Watkins LR, Hutchinson MR, Rice KC, Maier SF. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 2009;30(11):581-91.
41. Wilkie GI, Hutson PH, Stephens MW, Whiting P, Wonnacott S. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem Soc Trans 1993;21(2): 429-31.
42. Williams JT, Christie MJ, Manzoni O. Cellular and synaptic adaptations mediating opi-oid dependence. Physiol Rev 2001;81(1):299-343.
43. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 1997;20(2):92-8.
44. Yang X, Criswell HE, Breese GR. Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J Pharmacol Exp Ther 1996;276(2):482-9.
45. Zarrindast MR, Khoshayand MR, Shafaghi B. The development of cross-tolerance between morphine and nicotine in mice. Eur Neuropsychopharmacol 1999;9(3): 227-33.
46. Zenker N, Bernstein DE. The estimation of small amounts of corticosterone in rat plasma. J Biol Chem 1958;231(2):695-701.
47. Zhou FM, Liang Y, Dani JA. Endogenous nicotinic cholinergic activity regulates dopa-mine release in the striatum. Nat Neurosci 2001;4(12):1224-9.
48. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16(2):109-10.